HANDOK Inc. (KRX:002390)
11,460
+130 (1.15%)
Feb 14, 2025, 9:00 AM KST
HANDOK Revenue
HANDOK had revenue of 129.04B KRW in the quarter ending September 30, 2024, with 1.42% growth. This brings the company's revenue in the last twelve months to 512.66B, down -3.67% year-over-year. In the year 2023, HANDOK had annual revenue of 522.74B, down -3.87%.
Revenue (ttm)
512.66B
Revenue Growth
-3.67%
P/S Ratio
0.32
Revenue / Employee
544.80M
Employees
941
Market Cap
162.00B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 522.74B | -21.02B | -3.87% |
Dec 31, 2022 | 543.76B | 26.12B | 5.05% |
Dec 31, 2021 | 517.64B | 14.03B | 2.79% |
Dec 31, 2020 | 503.61B | 30.61B | 6.47% |
Dec 31, 2019 | 473.00B | 26.27B | 5.88% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Samsung Biologics | 4,364.39B |
Celltrion | 2,876.25B |
Yuhan | 2,008.84B |
SK Biopharmaceuticals | 511.33B |
SK bioscience | 201.30B |
Hanmi Pharm. | 1,495.50B |
Hanall Biopharma | 134.24B |
Hanmi Science | 1,283.65B |